Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

HAS

This page shows the latest HAS news and features for those working in and with pharma, biotech and healthcare.

Q&A: Niels Lund

Q&A: Niels Lund

What has been your career highlight to date? Seeing Cities Changing Diabetes go from a company-led initiative to becoming a global movement where municipalities, civil society organisations, public health officials,

Latest news

  • Genfit claims FDA breakthrough status for liver disease drug Genfit claims FDA breakthrough status for liver disease drug

    Elafibranor has shown promising anticholestatic effects in a Phase 2 clinical trial,” said Pascal Birman, Deputy Chief Medical Officer, Genfit. ... Meanwhile, Cymabay has its own NASH PPAR candidate in its pipeline, which is due for a crucial data

  • With Spiriva under pressure, Boehringer moves to bolster pipeline With Spiriva under pressure, Boehringer moves to bolster pipeline

    Forges alliance with PureTech Health. Boehringer Ingelheim has forged a $226m alliance with UK-listed biotech PureTech Health to develop a new approach to cancer immunotherapy. ... Spiriva is now off-patent in most markets but has been buffered from the

  • Novartis makes case for gene therapy Zolgensma in SMA Novartis makes case for gene therapy Zolgensma in SMA

    Zolgensma has been under review since the US medicines regulator granted a priority status back in December last year, when data was already looking strong for the gene therapy. ... Spinraza has been on the US market since 2016, and comes in at a list

  • Hemlibra off to a flyer as Roche raises 2019 forecasts Hemlibra off to a flyer as Roche raises 2019 forecasts

    Drug has made almost as much in this quarter as it did in 2018. ... All told, group sales rose 8% overall to CHF 14.83bn ($14.71bn), with pharma revenues up 10% on strong demand for the new crop of medicines, and Roche has now

  • Stem cell transplant firms Kiadis and CytoSen join forces Stem cell transplant firms Kiadis and CytoSen join forces

    Acquires an NK cell based platform with the deal. Dutch biotech Kiadis has agreed to acquire US counterpart CytoSen and pool their resources in the emerging field of cell-based cancer ... of defence for the body – and has shown promise as a therapy for

More from news
Approximately 1 fully matching, plus 7,313 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 865 partially matching documents found.

Latest appointments

  • Boehringer Ingelheim appoints Andreas Neumann as HR lead Boehringer Ingelheim appoints Andreas Neumann as HR lead

    He will also join the company's board ofmanaging directors. Andreas Neumann has been appointed to the board of managing directors at Boehringer Ingelheim, which has also handed him responsibility for

  • EM Imaging appoints new chairman EM Imaging appoints new chairman

    The Board of Edinburgh Molecular Imaging (EM Imaging) has appointed John Jeans as non-executive chairman. ... Jeans also chairs the board of UK Biocentre, and has sat on advisory panels for the MRC, EPSRC, NIHR and the Wellcome Trust. .

  • Cello Health BioConsulting appoints Jim Hall as president Cello Health BioConsulting appoints Jim Hall as president

    Senior pharma marketer to preside over newly-formed consulting firm. Cello Health BioConsulting has appointed senior pharma marketer Jim Hall as president.

  • Dr Reddy's makes senior changes as US generics head exits Dr Reddy's makes senior changes as US generics head exits

    UmangVohra will be replaced by Alok Sonig. Dr Reddy's has appointed Alok Sonig to be its new head of North America generics to take over from Umang Vohra (pictured). ... To fill Sonig's vacant role Dr Reddy's has handed MV Ramana, currently executive

  • CytomX appoints Rachel Humphrey chief medical officer CytomX appoints Rachel Humphrey chief medical officer

    Former VP of Eli Lilly and AstraZeneca joins the company. CytomX Therapeutics has appointed Dr Rachel Humphrey as chief medical officer. ... I am excited to now be joining the management team to help build a great company that has the potential to make a

More from appointments
Approximately 0 fully matching, plus 1,000 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1,017 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Quick links

Infographics

Multimedia